Lido Advisors’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CGTX
C
CM
Lido Advisors's CGTX Position: Q3 2026 in Review
Lido Advisors opened a new position in Cognition Therapeutics (CGTX) in Q3 2026: 46,149 shares worth $44.3K. The stake represents ﹤0.01% of the portfolio and ranks #2021 among its holdings.
78 funds tracked by Wall St. Rank hold CGTX as of Q3 2026.
- Lido Advisors held 46,149 shares of Cognition Therapeutics worth $44.3K as of Q3 2026.
- Cognition Therapeutics was a new Lido Advisors position in Q3 2026.
- Cognition Therapeutics made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #2021 holding.
- 78 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2026.
Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.